Celldex reports sustained angioedema improvements 7 months post-treatment
Go back to Celldex reports sustained angioedema improvements 7 months post-treatment| CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) | Delayed: 39.04 -0.64 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.68 | 52 Week High | $18.62 | |||
| Open | $38.78 | 52 Week Low | $2.85 | |||
| Day High | $39.87 | P/E | N/A | |||
| Day Low | $38.50 | EPS | $-1.02 | |||
| Volume | 618,292 | |||||
